Diabetes

A new study has highlighted the strong bidirectional relationship between chronic diabetes complications and mental health disorders in individuals with diabetes.

A recent cohort study has highlighted the potential of tirzepatide to significantly improve clinical outcomes in patients with Type 2 diabetes.

Discover how the NHS Type 2 Diabetes Path to Remission (T2DR) programme, has led to significant weight loss and diabetes remission in participants.

Researchers at Cardiff University have identified that Ustekinumab may effectively manage the early stages of Type 1 diabetes in children and adolescents.

According to recent findings, individuals who develop Type 1 diabetes face a heightened risk of mental health disorders.

COVID-19 infection has been associated with a rapid progression to clinical type 1 diabetes in young individuals with presymptomatic disease, according to a recent study.

New research suggests semaglutide, a medication for type 2 diabetes and obesity, may help reduce tobacco use disorder risks.

Novel findings showed a link between irregular sleep duration and the risk of developing diabetes, highlighting the potential metabolic consequences of sleep variability.